The largest database of trusted experimental protocols

2 protocols using anti human cd4 bv605

1

Suppressor T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Responder autologous PBMCs were labeled with 5 μM of CellTrace Violet (ThermoFisher) following manufacturer's protocol. 5 × 104 responder cells were plated on 96 round-bottom wells and co-cultured in complete RPMI 1640 medium [Life Technologies] (supplemented with penicillin, streptomycin, L-glutamine [Sigma-Aldrich], and 10% FCS [Natocor]) with unlabeled highly purified CD8+HLA-DR+ or CD8+HLA-DR- T cells in a responder: suppressor ratio of 1:1. Cells were stimulated with 1 μg/mL of plate-coated CD3 (Biolegend) and 1 μg/mL of soluble CD28 (Biolegend). On day 4 post-activation, cells were harvested, and proliferation of CellTrace Violet-labeled cells was assessed by flow cytometry. At this time point, cells were stained with anti-human CD3 FITC (Immunotools), anti-human CD4 BV605 (Biolegend) and anti-human CD8 APC (Immunotools), and incubated with 7-AAD (BD Bioscience) to analyze cytotoxicity and exclude dead cells. Percentage of suppression was calculated by dividing the number of proliferating CellTrace Violet-diluting responder cells in the presence of suppressor cells by the number of proliferating responder cells when cultured alone, multiplied by 100. Unlabeled, stimulated, and unstimulated cells were used as controls.
+ Open protocol
+ Expand
2

Activation of SARS-CoV-2-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To minimize measurement errors, freshly isolated PBMCs were preserved in liquid nitrogen until the last follow-up was completed. Upon detection, the PBMCs isolated at the baseline and 4 weeks post the 2nd dose were recovered and washed twice with R10 (RPMI1640 with 10% FBS). After counting, 1 million live (trypan blue negative) cells from each sample were added to 96-well round bottom plates and incubated with either R10 or R10 containing synthesized spike protein peptides (0.6μg/ml for each peptide) overnight. Then, the cells were washed and stained sequentially with live/dead dye(Zombie Aqua Fixable Viability Kit, cat#423101, BioLegend), surface marker antibodies (Anti-human-CD3-APC/cyanine 7, cat#300318, BioLegend; anti-human-CD4-BV605, cat#566148, BioLegend; anti-human-CD8-APC, cat#344722, BioLegend; anti-human-HLA-DR-BV421, cat#307636, BioLegend; anti-human-CD38-Percp-Cy5·5, cat#551400, BD Pharmingen) and an intracellular IFN-γ antibody (anti-human-IFN-γ-PE, cat#502509, BioLegend). Stained samples were analyzed using a BD Fortessa flow cytometer and data were analyzed with FlowJo software version 10 (TreeStar Inc., Ashland, OR, USA). The gating strategy is shown in Supplementary figure 2. The evaluation of T cell activation was based on the data generated from wells incubated with R10.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!